As a result, monitoring whether investment staff owning hedge funds may benefit personally and improperly in connection with state pension investments is highly problematic.
The project will develop a result-based monitoring system in line with the Paris Declaration to ensure its effectiveness, while providing more intensive technical support.
As a result of the positive interim analysis, the FAME II independent Data Safety Monitoring Board (DSMB) has recommended investigators stop patient enrollment in this trial as the DSMB considers it unethical to continue to randomize patients to optimal medical therapy (OMT) alone.